Translational Physician-Scientist Training Program in Oncology

描述（由申请人提供）：埃默里大学血液学和内科肿瘤学系（HMO）和Winship癌症研究所提出了肿瘤学T32转化医生-科学家培训计划。这个为期2.5年的培训计划（包括由HMO部门内部资助的6个月，以及2年的T32资金支持）将使血液学/肿瘤学研究员获得基础/转化研究方法的强有力教育，最终目标是为每位学员建立独立的研究计划。许多研究都记录了医生-科学家管道的损耗，这在很大程度上是由于在获得赠款资金方面面临的挑战。 提供高水平的指导和支持是必要的，以培养年轻的医生-科学家的发展，并将他们留在学术机构。 该培训计划旨在（1）提供一个足够大的导师库，从中为每位学员选择最合适的研究课题;（2）通过与不同专业的基础和临床研究人员的互动，促进癌症护理和以患者为导向的研究的多学科方法; (3)在研究设计、方法和分析方面提供指导，以促进转化肿瘤学领域发展中的医生-科学家的独立性，重点关注实体肿瘤，主要包括头颈部、肺、乳腺、胃肠道和泌尿生殖系统恶性肿瘤;（4）指导受训人员制定和提交第一份资助申请。 该培训计划将每年招募2名住院医师，他们具有2-3年的内科临床培训经验，强烈希望发展基础科学研究技能， 肿瘤学，以及对学术医学的承诺。所有学员最初将被招募到现有的血液学/肿瘤学奖学金计划，并将首先完成PGY-4和PGY-5上半年奖学金的18个月临床要求（以满足ACGME的董事会killbilty要求）。然后，受训人员将进行2.5年的T32培训计划研究，从PGY-5的下半年到PGY-7，这将包括在研究设计，方法和分析，在职业发展和赠款准备支持密切指导，并在严格定义的培训课程的参与。培训将侧重于成功的学术生涯的关键要素，特别是会议演讲，手稿出版物和独立研究资金申请的进展。 通过对肿瘤学翻译医生科学家培训计划的坚定承诺，埃默里HMO部门和Winship打算积极为培训和指导下一代医生科学家肿瘤学家做出贡献，在他们学术研究生涯的早期阶段支持他们。

DESCRIPTION (provided by applicant): The Department of Hematology and Medical Oncology (HMO) and the Winship Cancer Institute at Emory University proposes a T32 Translational Physician-Scientist Training Program in Oncology. This 2.5-year Training Program (including 6 months funded internally by the HMO Department, and 2 years of T32 funding support) will enable hematology/oncology fellows to acquire a strong education in basic/translational research approaches, with the ultimate goal of establishing an independent research program for each trainee. Many studies have documented the attrition of the physician-scientist pipeline, due in large part to the challenges faced in obtaining grant funding. Providing a high level of mentoring and support is necessary to nurture the development of young physician-scientists and retain them in academic institutions. The Training Program aims to (1) provide a sufficiently large mentor pool from which to select the most appropriate research topic(s) for each trainee; (2) foster a multidisciplinary approach to cancer care and patient-oriented research through interaction with basic and clinical investigators of diverse specialties; (3) provide guidance in research design, methodology and analysis that will foster the independence of developing physician-scientists in the field of translational oncology, focused on solid tumors mainly including head and neck, lung, breast, gastrointestinal and genitourinary malignancies; and (4) guide trainees through the development and submission of their first grant application(s). The Training Program will recruit 2 residents per year with 2-3 years of prior clinical training in internal medicine, a strong desire to develop basic science research skills in oncology, and a commitment to academic medicine. All trainees will initially be recruited to the existing Hematology/Oncology Fellowship Program, and will first complete 18 months of clinical requirements for the fellowship in PGY-4 and the first half of PGY-5 (to fulfill the board eligibilty requirements of the ACGME). Trainees will then undertake 2.5 years of T32 Training Program research, from the second half of PGY-5 through PGY-7, which will encompass close mentoring in research design, methodology and analysis, support in career development and grant preparation, and participation in a rigorously defined training curriculum. Training will focus on elements critical for a successful academic career, particularly progress towards conference presentations, manuscript publications, and applications for independent research funding. Through its strong commitment to the proposed Translational Physician-Scientist Training Program in Oncology, the Emory HMO Department and the Winship intend to actively contribute to training and mentoring the next generation of physician-scientist oncologists, supporting them in the early steps of their academic research careers.